Endovascular Aneurysm Repair Market by Indication and Product With top key Players: Medtronic plc., Cook Medical Inc., Endologix, Inc., Lombard Medical, Inc., W. L. Gore & Associates, Inc and Cardinal Health Inc.

the endovascular aneurysm repair market was valued at $2,327 million in 2016, and is projected to reach $3,580 million by 2023, growing at a CAGR of 6.2% from 2017 to 2023. The abdominal aortic aneurysm (AAA) segment accounted for nearly seventh-ninth share of the total market in 2016.

EVAR is a procedure used in treatment of abdominal and thoracic aortic aneurysm. During the EVAR procedure, the endovascular stent graft is placed in the aneurysm area to provide alternative channel for blood flow. This excludes the aneurysm sac from blood flow pressure. Hence, prevents the walls of aneurysm from rupturing (that may lead to hemorrhage or excessive bleeding).

Get sample copy of this report at:
www.alliedmarketresearch.com/request-sample/1879

EVAR procedure employing endovascular stent graft provides suitable alternative to open surgery as it does not require any surgical opening. At present, the adoption of EVAR procedures are in high demand, owing to its minimally invasive nature and quick recovery. For instance, in U.S., around 70% of a total 70,000 abdominal aortic repair cases are accomplished by EVAR.

The traditional aneurysm is defined as aneurysm with aortic neck length more than or equal to 10mm. The traditional anatomy segment dominated the EVAR market by anatomy with three-fourths of the total share in 2016. The market for traditional aneurysm is attributed by the fact that majority of the cases registered in hospitals of aneurysm are more than 10mm. The complex anatomy market segment is expected to grow at a highest CAGR of 9.2% from 2017 to 2023.

Key Findings of the Endovascular Aneurysm Repair (Evar) Market:

• The pararenal segment is anticipated to grow at a highest rate during the analysis period.
• U.S. was the major shareholder in the North America endovascular aneurysm repair market, accounted for the highest share in 2016.
• The traditional segment occupied about three-fourth share of the total EVAR market by anatomy in 2016 and expected to retain its dominant share throughout the forecast period.
• China occupied two-ninth share of the total Asia-Pacific endovascular aneurysm repair market in 2016, registering a high CAGR of 11.2% from 2017 to 2023.
• The percutaneous EVAR product segment dominated the endovascular aneurysm repair market in 2016, growing at a CAGR of 6.9% from 2017 to 2023.
• The juxtarenal segment accounted for the seventh-ninth share in pararenal site in 2016.

Send Enquiry on this report @
https://www.alliedmarketresearch.com/purchase-enquiry/1879

The infrarenal site dominated the EVAR market with more than sixth-seventh share in 2016. This is due to the elevated rate of occurrence of abdominal aneurysm at infrarenal site. Around 110,000 procedures using EVAR were performed globally in 2016, to treat infrarenal abdominal aortic aneurysm. Hence, owing to the high prevalence of infrarenal abdominal aortic aneurysm it primarily contributes to the market growth. The pararenal site of EVAR market is expected to grow at a CAGR of 7.1% from 2017 to 2023.

Key players in the market:

• Medtronic plc.
• Cook Medical Inc.
• Endologix Inc.
• Lombard Medical Inc.
• W. L. Gore & Associates Inc.
• Cardinal Health Inc.
• C. R. Bard Inc.
• Merck & Co.Inc.
• Terumo Corporation
• Abbott Laboratories.

Access full summary @ https://www.alliedmarketresearch.com/endovascular-aneurysmr-repair-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Sona Padman
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.